Categories Earnings, Other Industries

Takeda likely to make a move for Shire

Japanese pharma giant Takeda Pharmaceuticals is said to be planning to bid for London’s leading drug company Shire Pharmaceuticals (Nasdaq: SHPG). The news sent Shire’s stock soaring more than 25% during the morning session in the U.K. market and it surged 18% in the U.S. market.

Shire, which has a market value of around $46.4 billion, focuses on rare disease treatments and hyperactivity medicines. Two months ago, the U.K. drugmaker announced plans to split its business into two divisions.

Shire has been struggling with stiff generic drug competition as well as heavy debt since its acquisition of Baxalta two years ago and has seen its shares drop over 20%. Takeda said the deal would bring opportunities for expansion in rare diseases therapy as well as the areas of neuroscience, oncology and gastrointestinal.

Takeda likely to bid for Shire
Takeda Pharmaceutical Tokyo head office (Courtesy: Wikimedia Commons)

Takeda also sees an opportunity to gain market share in the United States through this deal. Takeda said it has not formally notified Shire of its intentions as the Japanese company is still mulling the various aspects of the deal. There is also no guarantee that a bid or deal will be made.

Takeda has plans to expand its footprint globally and it is looking for more deals and partnerships that will help it move towards this goal. The company wants to find new partners in the area of research and it is also striving to move its products through the pipeline to more advanced stages of development.

Two months ago, the U.K. drugmaker announced plans to split its business into two divisions.

The bid on Shire by Takeda is likely to attract other pharma giants like Pfizer (PFE) or Novartis (NVS) into the bidding arena. The healthcare industry is seeing a number of transactions like GlaxoSmithKline’s (GSK) purchase of Novartis’ stake in their JV and the ongoing bid for Pfizer’s consumer healthcare business.

Most Popular

AMAT Earnings: Applied Materials Q1 2025 adj. profit rises on higher sales

Applied Materials, Inc. (NASDAQ: AMAT), a leading supplier of equipment and software for manufacturing semiconductor chips and flat panel displays, Thursday reported an increase in sales and adjusted earnings for

Cisco Systems (CSCO) bets on strong AI demand to drive growth

After starting the fiscal year on a weak note, Cisco Systems Inc. (NASDAQ: CSCO) has regained momentum, reporting higher second-quarter revenue and profit that beat analysts’ estimates. The company is

What to expect when Hasbro (HAS) reports its fourth quarter 2024 earnings results

Shares of Hasbro, Inc. (NASDAQ: HAS) stayed green on Thursday. The stock has gained 7% year-to-date. The toymaker is scheduled to report its fourth quarter 2024 earnings results on Thursday,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top